SEATTLE, Jan. 27, 2025 (GLOBE NEWSWIRE) -- (Umoja), the clinical-stage leader of in vivo cell therapies that aim to realize the full reach and promise of CAR T cells, today announced the appointment ...

Merck & Co (NYSE:MRK)., the second-largest U.S. drugmaker by revenue, is facing a jury trial over accusations that it ...

Merck & Co. has won U.S. Food and Drug Administration priority review for its application seeking expanded use of its Welireg oral cancer drug in patients with rare tumors that form in and around the ...

Robert F. Kennedy Jr. plans to continue earning from legal cases while heading the Department of Health and Human Services, ...

Merck & Co. is facing its first jury trial over claims the company wrongfully marketed its lucrative Gardasil cancer vaccine as safe, the latest high-stakes litigation for the pharmaceutical giant.

In a report released on January 24, Daina Graybosch from Leerink Partners maintained a Buy rating on Merck & Company (MRK – Research ...

The Japanese pharma had one asset rejected by the FDA and withdrew a regulatory application for another, but already this ...

The first week of President Donald Trump’s second term included several executive orders and actions that will be detrimental ...

Robert F. Kennedy Jr. is set to appear before the Senate Finance Committee for the first of two confirmation hearings as ...

The Dow Jones Industrial Average (DJIA) is a group of 30 U.S. industry leaders. It's often looked at as a proxy for the ...

Patients with a common heart rhythm disorder who took an experimental blood-thinning drug had far fewer bleeding episodes ...

RFK Jr. faces unified opposition for HHS post; Trump disrupts NIH proceedings; Biogen CEO tells Mass. Gov there is “policy ...